Brain profile of hypometabolism in early Alzheimer's disease: Relationships with cognitive deficits and atrophy;Profil d'hypométabolisme au stade précoce de la maladie d'Alzheimer: Lien avec les déficits mnésiques et le profil d'atrophie

Revue Neurologique

Volumn 162, Issue 10, 2006, Pages 945-951

  Chetelat G ^a,b   Desgranges, B ^a   Eustache, F ^a  

^a GIP CYCERON   (France)

^b PSL RESEARCH UNIVERSITY   (France)

Author keywords

Alzheimer's disease; Atrophy; Episodic memory; Hippocampus; Positron emission tomography (PET)

Indexed keywords

ALZHEIMER DISEASE; CLINICAL FEATURE; COGNITION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONFERENCE PAPER; HIPPOCAMPUS; HUMAN; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 33749367318     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0035-3787(06)75104-9     Document Type: Conference Paper

References (72)

1. ALEXANDER GE, CHEN K, PIETRINI P, RAPOPORT SI, REIMAN EM. (2002). Longitudinal PET evaluation of cerebral metabolic decline in dementia: a potential outcome measure in Alzheimer's disease treatment studies. Am J Psychiatry, 159: 738-745.
2. ANCHISI D, BORRONI B, FRANCESCHI M et al. (2005). Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease. Arch Neurol, 62: 1728-1733.
3. BACKMAN L, SMALL BJ. (1998). Influences of cognitive support on episodic remembering: tracing the process of loss from normal aging to Alzheimer's disease. Psychol Aging, 13: 267-276.
4. BERENT S, GIORDANI B, FOSTER N et al. (1999). Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimer's disease. J Psychiatr Res, 33: 7-16.
5. BLACKWELL AD, SAHAKIAN BJ, VESEY R, SEMPLE JM, ROBBINS TW, HODGES JR. (2004). Detecting dementia: novel neuropsychological markers of preclinical Alzheimer's disease. Dement Geriatr Cogn Disord, 17: 42-48.
6. BONDI MW, HOUSTON WS, EYLER LT, BROWN GG. (2005). fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology, 64: 501-508.
7. BOOKHEIMER SY, STROJWAS MH, COHEN MS et al. (2000). Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med, 343: 450-456.
8. CABEZA R, NYBERG L. (2000). Imaging cognition II: An empirical review of 275 PET and fMRI studies. J Cogn Neurosci, 12: 1-47.
9. CHÉTELAT G, DESGRANGES B, DE LA SAYETTE V et al. (2003a). Dissociating atrophy and hypometabolism impact on episodic memory in mild cognitive impairment. Brain, 126: 1955-1967.
10. CHÉTELAT G, DESGRANGES B, DE LA SAYETTE V, VIADER F, EUSTACHE F, BARON JC. (2003b). Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease? Neurology, 60: 1374-1377.
11. CHÉTELAT G, EUSTACHE F, VIADER F et al. (2005a). FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment. Neurocase, 11: 14-25.
12. DE LEON MJ, MCRAE T, RUSINEK H et al. (1997). Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer's disease. J Clin Endocrinol Metab, 82: 3251-3259.
13. DE LEON MJ, CONVIT A, WOLF OT et al. (2001). Prediction of cognitive decline in normal elderly subjects with 2- [(18)F]fluoro-2-deoxy-D-glucose/ positron-emission tomography (FDG/PET). Proc Natl Acad Sci USA, 98: 10966-10971.
14. DE SANTI S, DE LEON MJ, RUSINEK H et al. (2001). Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol Aging, 22: 529-539.
15. DESGRANGES B, BARON JC, DE LA SAYETTE V et al. (1998). The neural substrates of memory systems impairment in Alzheimer's disease. A PET study of resting brain glucose utilization. Brain, 121: 611-631.
16. DESGRANGES B, BARON JC, LALEVÉE C et al. (2002). The neural substrates of episodic memory impairment in Alzheimer's disease as revealed by FDG-PET: relationship to degree of deterioration. Brain, 125: 1116-1124.
17. DEVANAND DP, FOLZ M, GORLYN M, MOELLER JR, STERN Y. (1997). Questionable dementia: clinical course and predictors of outcome. J Am Geriatr Soc, 45: 321-328.
18. DICKERSON BC, SALAT DH, BATES JF et al. (2004). Medial temporal lobe function and structure in mild cognitive impairment. Ann Neurol, 56: 27-35.
19. DICKERSON BC, SALAT DH, GREVE DN et al. (2005). Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology, 65: 404-411.
20. DRZEZGA A, LAUTENSCHLAGER N, SIEBNER H et al. (2003). Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study. Eur J Nucl Med Mol Imaging, 30: 1104-1113.
21. EUSTACHE F, DESGRANGES B, LALEVÉE C. (1998). Clinical evaluation of memory. [French]. Rev Neurol (Paris), 154: S18-S32.
22. EUSTACHE F, DESGRANGES B, GIFFARD B, DE LA SAYETTE V, BARON JC. (2001). Entorhinal cortex disruption causes memory deficit in early Alzheimer's disease as shown by PET. Neuroreport, 12: 683-685.
23. EUSTACHE F, PIOLINO P, GIFFARD B et al. (2004). "In the course of time": a PET study of the cerebral substrates of autobiographical amnesia in Alzheimer's disease. Brain, 127: 1549-1560.
24. FABRIGOULE C, ROUCH I, TABERLY A et al. (1998). Cognitive process in preclinical phase of dementia. Brain, 121: 135-141.
25. FLEISHER AS, HOUSTON WS, EYLER LT et al. (2005). Identification of Alzheimer disease risk by functional magnetic resonance imaging. Arch Neurol, 62: 1881-1888.
26. FLICKER C, FERRIS SH, REISBERG B. (1991). Mild cognitive impairment in the elderly: predictors of dementia. Neurology, 41: 1006-1009.
27. FRACKOWIAK RS, POZZILLI C, LEGG NJ et al. (1981). Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. Brain, 104: 753-778.
28. GARRIDO GE, FURUIE SS, BUCHPIGUEL CA et al. (2002). Relation between medial temporal atrophy and functional brain activity during memory processing in Alzheimer's disease: a combined MRI and SPECT study. J Neurol Neurosurg Psychiatry, 73: 508-516.
29. HANNINEN T, HALLIKAINEN M, KOIVISTO K et al. (1995). A follow-up study of age-associated memory impairment: neuropsychological predictors of dementia. J Am Geriatr Soc, 43: 1007-1015.
30. HERHOLZ K, SCHOPPHOFF H, SCHMIDT M et al. (2002). Direct comparison of spatially normalized PET and SPECT scans in Alzheimer's disease. J Nucl Med, 43: 21-26.
31. HIRAO K, OHNISHI T, HIRATA Y et al. (2005). The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT. NeuroImage, 28: 1014-1021.
32. HOWIESON DB, DAME A, CAMICIOLI R, SEXTON G, PAYAMI H, KAYE JA. (1997). Cognitive markers preceding Alzheimer's dementia in the healthy oldest old. J Am Geriatr Soc, 45: 584-589.
33. HUANG C, WAHLUND LO, ALMKVIST O et al. (2003). Voxel- and VOI-based analysis of SPECT CBF in relation to clinical and psychological heterogeneity of mild cognitive impairment. Neuroimage, 19: 1137-1144.
34. IBANEZ V, PIETRINI P, ALEXANDER GE et al. (1998). Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology, 50: 1585-1593.
35. ISHII K, SASAKI M, YAMAJI S, SAKAMOTO S, KITAGAKI H, MORI E. (1997). Demonstration of decreased posterior cingulate perfusion in mild Alzheimer's disease by means of H215O positron emission tomography. Eur J Nucl Med, 24: 670-673.
36. ISHII K, WILLOCH F, MINOSHIMA S et al. (2001). Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains. J Nucl Med, 42: 548-557.
37. JIN K, PEEL AL, MAO XO et al. (2004). Increased hippocampal neurogenesis in Alzheimer's disease. Proc Natl Acad Sci USA, 101: 343-347.
38. JOHNSON KA, LOPERA F, JONES K et al. (2001). Presenilin-1-associated abnormalities in regional cerebral perfusion. Neurology, 56: 1545-1551.
39. JOHNSON SC, SCHMITZ TW, MORITZ CH et al. (2006). Activation of brain regions vulnerable to Alzheimer's disease: The effect of mild cognitive impairment. Neurobiol Aging, sous press.
40. KARNATH HO. (2001). New insights into the functions of the superior temporal cortex. Nat Rev Neurosci, 2: 568-576.
41. KATO T, KNOPMAN D, LIU H. (2001). Dissociation of regional activation in mild AD during visual encoding: a functional MRI study. Neurology, 57: 812-816.
42. KAWACHI T, ISHII K, SAKAMOTO S et al. (2006). Comparison of the diagnostic performance of FDG-PET and VBM-MRI in very mild Alzheimer's disease. Eur J Nucl Med Mol Imaging, sous press.
43. KAWAS CH, CORRADA MM, BROOKMEYER R et al. (2003). Visual memory predicts Alzheimer's disease more than a decade before diagnosis. Neurology, 60: 1089-1093.
44. KUMAR A, SCHAPIRO MB, GRADY C et al. (1991). High-resolution PET studies in Alzheimer's disease. Neuropsychopharmacology, 4: 35-46.
45. MACHULDA MM, WARD HA, BOROWSKI B et al. (2003). Comparison of memory fMRI response among normal, MCI, and Alzheimer's patients. Neurology, 61: 500-506.
46. MASUR DM, SLIWINSKI M, LIPTON RB, BLAU AD, CRYSTAL HA. (1994). Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology, 44: 1427-1432.
47. MATSUDA H. (2001). Cerebral blood flow and metabolic abnormalities in Alzheimer's disease. Ann Nucl Med, 15: 85-92.
48. MCKHANN G, DRACHMAN D, FOLSTEIN M, KATZMAN R, PRICE D, STADLAN EM. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34: 939-944.
49. MEGURO K, BLAIZOT X, KONDOH Y, LE MESTRIC C, BARON JC, CHAVOIX C. (1999). Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET. Implications for Alzheimer's disease. Brain, 122: 1519-1531.
50. MINOSHIMA S, FOSTER NL, KUHL DE. (1994). Posterior cingulate cortex in Alzheimer's disease. Lancet, 344: 895.
51. MINOSHIMA S, GIORDANI B, BERENT S, FREY KA, FOSTER NL, KUHL DE. (1997). Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol, 42: 85-94.
52. MOSCONI L, PERANI D, SORBI S et al. (2004). MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET. Neurology, 63: 2332-2340.
53. MOSCONI L. (2005). Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging, 32: 486-510.
54. NAGAHAMA Y, NABATAME H, OKINA T et al. (2003). Cerebral correlates of the progression rate of the cognitive decline in probable Alzheimer's disease. Eur Neurol, 50: 1-9.
55. NESTOR PJ, FRYER TD, IKEDA M, HODGES JR. (2003a). Retrosplenial cortex (BA 29/30) hypometabolism in mild cognitive impairment (prodromal Alzheimer's disease). Eur J Neurosci, 18: 2663-2667.
56. NESTOR PJ, FRYER TD, SMIELEWSKI P, HODGES JR. (2003b). Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment. Ann Neurol, 54: 343-351.
57. NESTOR PJ, SCHELTENS P, HODGES JR. (2004). Advances in the early detection of Alzheimer's disease. Nat Med, 10: S34-S41.
58. OUCHI Y, NOBEZAWA S, OKADA H, YOSHIKAWA E, FUTATSUBASHI M, KANEKO M. (1998). Altered glucose metabolism in the hippocampal head in memory impairment. Neurology, 51: 136-142.
59. PARIENTE J, COLE S, HENSON R et al. (2005). Alzheimer's patients engage an alternative network during a memory task. Ann Neurol, 58: 870-879.
60. PERANI D, BRESSI S, CAPPA SF et al. (1993). Evidence of multiple memory systems in the human brain. A 18FDG metabolic study. Brain, 116: 903-919.
61. PETERSEN RC, DOODY R, KURZ A et al. (2001). Current concepts in mild cognitive impairment. Arch Neurol, 58: 1985-1992.
62. REIMAN EM, CASELLI RJ, YUN LS et al. (1996). Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med, 334: 752-758.
63. REIMAN EM, CHEN K, ALEXANDER GE et al. (2004). Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci USA, 101: 284-289.
64. RÉMY F, MIRRASHED F, CAMPBELL B, RICHTER W. (2005). Verbal episodic memory impairment in Alzheimer's disease: a combined structural and functional MRI study. Neuroimage, 25: 253-266.
65. RIES ML, SCHMITZ TW, KAWAHARA TN, TORGERSON BM, TRIVEDI MA, JOHNSON SC. (2006). Task-dependent posterior cingulate activation in mild cognitive impairment. Neuroimage, 29: 485-492.
66. ROMBOUTS SA, BARKHOF F, VELTMAN DJ et al. (2000). Functional MR imaging in Alzheimer's disease during memory encoding. AJNR Am J Neuroradiol, 21: 1869-1875.
67. SMALL GW, MAZZIOTTA JC, COLLINS MT et al. (1995). Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA, 273: 942-947.
68. SMALL GW, ERCOLI LM, SILVERMAN DH et al. (2000). Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci USA, 97: 6037-6042.
69. SPERLING RA, BATES JF, CHUA EF et al. (2003). fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease. J Neurol Neurosurg Psychiatry, 74: 44-50.
70. STORANDT M, GRANT EA, MILLER JP, MORRIS JC. (2002). Rates of progression in mild cognitive impairment and early Alzheimer's disease. Neurology, 59: 1034-1041.
71. SWAINSON R, HODGES JR, GALTON CJ et al. (2001). Early detection and differential diagnosis of Alzheimer's disease and depression with neuropsychological tasks. Dement Geriatr Cogn Disord, 12: 265-280.
72. TIAN J, BUCKS R.S, HAWORTH J, WILCOCK G. (2005). Neuropsychological prediction of conversion to dementia from questionable dementia: statistically significant but not yet clinically useful. Journal of Neurology, Neurosurgery, and Psychiatry, 74: 433-438.